title: Prescribing of venlafaxine and dosulepin in primary care.
authors.forename: R Hamish
authors.initials: RH
authors.lastname: McAllister-Williams
authors.forename: Karin
authors.initials: K
authors.lastname: Foran
authors.forename: Steven
authors.initials: S
authors.lastname: Forrest
authors.forename: Graham
authors.initials: G
authors.lastname: Ingram
authors.forename: Lindsay
authors.initials: L
authors.lastname: McMahon
authors.forename: Michelle
authors.initials: M
authors.lastname: Taylor
authors.forename: Madhuri S
authors.initials: MS
authors.lastname: Rajwal
authors.forename: Peter L
authors.initials: PL
authors.lastname: Cornwall
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004308:Dothiepin / Q000009:adverse effects* / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D011320:Primary Health Care; D013405:Suicide / Q000523:psychology; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D004308:Dothiepin